Schmidlin Fabien, Roosterman Dirk, Bunnett Nigel W
Department of Surgery, University of California, San Francisco, 521 Parnassus Ave., San Francisco, CA 94143-0660, USA.
Am J Physiol Cell Physiol. 2003 Oct;285(4):C945-58. doi: 10.1152/ajpcell.00541.2002.
Tachykinins interact with three neurokinin receptors (NKRs) that are often coexpressed by the same cell. Cellular responses to tachykinins depend on the NKR subtype that is activated. We compared the colocalization of NK1R and NK3R with beta-arrestins 1 and 2, which play major roles in receptor desensitization, endocytosis, and signaling. In cells expressing NK1R, the selective agonist Sar-Met-substance P induced rapid translocation of beta-arrestins 1 and 2 from the cytosol to the plasma membrane and then endosomes, indicative of interaction with both isoforms. In contrast, the NK3R interacted transiently with only beta-arrestin 2 at the plasma membrane. Despite these differences, both NK1R and NK3R similarly desensitized, internalized, and activated MAP kinases. Because interactions with beta-arrestins can explain differences in the rate of receptor resensitization, we compared resensitization of agonist-induced Ca2+ mobilization. The NK1R resensitized greater than twofold more slowly than the NK3R. Replacement of intracellular loop 3 and the COOH tail of the NK1R with comparable domains of the NK3R diminished colocalization of the NK1R with beta-arrestin 1 and accelerated resensitization to that of the NK3R. Thus loop 3 and the COOH tail specify colocalization of the NK1R with beta-arrestin 1 and determine the rate of resensitization.
速激肽与三种神经激肽受体(NKRs)相互作用,这些受体常由同一细胞共表达。细胞对速激肽的反应取决于被激活的NKR亚型。我们比较了NK1R和NK3R与β-抑制蛋白1和2的共定位情况,β-抑制蛋白1和2在受体脱敏、内吞作用和信号传导中起主要作用。在表达NK1R的细胞中,选择性激动剂Sar-Met-速激肽诱导β-抑制蛋白1和2从细胞质快速转运至质膜,然后进入内体,这表明它们与两种亚型均有相互作用。相比之下,NK3R仅在质膜上与β-抑制蛋白2短暂相互作用。尽管存在这些差异,但NK1R和NK3R在脱敏、内化和激活丝裂原活化蛋白激酶方面表现相似。由于与β-抑制蛋白的相互作用可以解释受体再敏化速率的差异,我们比较了激动剂诱导的Ca2+动员的再敏化情况。NK1R的再敏化速度比NK3R慢两倍多。用NK3R的相应结构域替换NK1R的细胞内环3和COOH末端,减少了NK1R与β-抑制蛋白1的共定位,并加速了其再敏化至NK3R的水平。因此,环3和COOH末端决定了NK1R与β-抑制蛋白1的共定位,并决定了再敏化的速率。